Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00829140 · ClinicalTrials.gov registry record · Phase 1
To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake
A Phase 1 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT00829140: Completed Phase 1 study, sponsored by Eisai.
NCT00829140 is a Phase 1 study that has completed, run by Eisai. The registered enrollment target is 56 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00829140, a Phase 1 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of lorcaserin on energy metabolism and food intake in obese and overweight patients.
Interventions
- DRUG Placebo
- DRUG Lorcaserin 10mg BID
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-02 |
| Phase | Phase 1 |
What the finished NCT00829140 record still lists
NCT00829140 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00829140 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00829140 about?
NCT00829140 is a clinical study titled "To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake". The purpose of this study is to evaluate the effect of lorcaserin on energy metabolism and food intake in obese and overweight patients.
What is the current status of trial NCT00829140?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2008-11. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00829140?
The interventions under investigation include: Placebo (DRUG), Lorcaserin 10mg BID (DRUG).
Who is sponsoring clinical trial NCT00829140?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00829140's enrollment target sits among peer trials
56 902nd of 2000 higher than 1,083 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia